Age median (IQR) 38 (33-46)
>50 years, n(%) 30 (13)
≤50 years, n(%) 201 (87)
Female 160 (69.26)
HIV type 1, n(%) 221 (95.67)
Baseline CD4 cells count median (IQR) 148 (78-220)
<200/mm3, n(%) 158 (68.4)
≥200/mm3, n(%) 73 (31.6)
Karnofsky score, median (IQR) 90 (90-90)
CDC Clinic stage stage A or B, n(%) 172 (74.46)
stage C, n(%) 59 (25.54)
Presence of opportunistic infections, n(%) 158 (68.4)
  NNRTI-based regimens NVP-based regimen, n(%) 192 (88.9)
EFV-based regimen, n(%) 24 (11.1)
PI-based regimen, n(%) 9 (3.9)
3 NRTIs regimen, n(%) 6 (2.6)
Cotrimoxazole prophylaxis, n(%) 208 (90)
Socio-economic condition Low condition, n(%) 185 (80.10%)
Medium or high condition, n(%) 46 (19.9%)
Housing condition Standing, n(%) 110 (47.7%)
Modest, n(%) 115 (49.8%)
Precarious, n(%) 6 (2.6%)
Education Illiteracy or primary school level, n(%) 137 (85.7%)
Secondary or high school level, n(%) 94 (40.7%)
IQR: interquartile range
Table 1: Patients’ baseline features.
Goto home»